MEEDER ASSET MANAGEMENT INC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$8,000
+14.3%
1860.0%0.00%
Q2 2022$7,0000.0%1860.0%0.00%
Q1 2022$7,000186
+1228.6%
0.00%
Q3 2021$0
-100.0%
140.0%0.00%
Q2 2021$1,0000.0%140.0%0.00%
Q1 2021$1,0000.0%14
+7.7%
0.00%
Q4 2020$1,0000.0%13
-58.1%
0.00%
Q3 2020$1,000
-75.0%
31
-49.2%
0.00%
Q2 2020$4,000
+100.0%
61
+45.2%
0.00%
Q1 2020$2,000
-99.1%
42
-98.8%
0.00%
-100.0%
Q4 2019$219,000
+7200.0%
3,616
+6596.3%
0.01%
Q3 2019$3,000
+50.0%
54
+100.0%
0.00%
Q2 2019$2,000
-98.9%
27
-98.8%
0.00%
-100.0%
Q1 2019$184,000
-96.1%
2,256
+1914.3%
0.02%
Q2 2018$4,667,000
+29068.8%
112
-63.8%
0.00%
-100.0%
Q4 2017$16,000
+700.0%
309
+602.3%
0.00%
Q3 2017$2,000
-87.5%
44
-89.3%
0.00%
-100.0%
Q1 2017$16,000
-80.7%
410
-76.5%
0.00%
-87.5%
Q4 2016$83,0001,7430.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,136$133,7497.12%
Bellevue Group AG 9,743,900$368,027,1034.88%
M28 Capital Management LP 126,300$4,770,3514.55%
Sicart Associates LLC 246,258$9,301,1653.28%
Camber Capital Management LP 1,925,000$72,7072.49%
Privium Fund Management B.V. 148,807$5,557,9412.11%
Deep Track Capital, LP 1,205,773$45,542,0461.91%
BVF INC/IL 1,121,809$42,370,7261.79%
Orbimed Advisors 1,993,600$75,298,2721.44%
Parkman Healthcare Partners LLC 141,115$5,329,9141.42%
View complete list of IONIS PHARMACEUTICALS INC shareholders